🔗 Permalink

Inventor profile of:

Ting Yang

City:

Shanghai

Country:

China

Published Applications:

Last publication date:

2025-07-24

Top Assignees for applications by Ting Yang

The entities that hold a legal rights for patent applications filed by inventor Yang Ting:

HUAWEI TECHNOLOGIES CO., LTD. 2 Shenzhen, China
GlaxoSmithKline Intellectual Property Development Limited 2 Brentford, Middlesex, United Kingdom
Glaxosmithline Intellectual Property Development Limited 1 Brentford, Middlesex, United Kingdom

Recent patent applications by Yang Ting

Ting Yang from Shanghai, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-07-24

US20250235543A1

Human necessities

MODIFIED PROTEINS AND PROTEIN DEGRADERS

#2 | 2025-07-10

US20250221988A1

Human necessities

COMPOUNDS AND METHODS OF TREATING CANCERS

#3 | 2024-10-10

US20240335452A1

Human necessities

COMPOSITIONS AND METHODS OF COMBINATION THERAPY FOR TARGETING LYMPHOMA

#4 | 2024-07-25

US20240246955A1

Chemistry; metallurgy

TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE

#5 | 2024-06-20

US20240197694A1

Human necessities

MODIFIED PROTEINS AND PROTEIN BINDERS

#6 | 2024-02-22

US20240059671A1

Chemistry; metallurgy

TYROSINE KINASE 2 (TYK2) DEGRADATION COMPOUNDS AND METHODS OF USE

#7 | 2024-02-15

US20240050428A1

Human necessities

COMPOUNDS AND METHODS OF TREATING CANCERS

#8 | 2023-11-16

US20230371095A1

Electricity

CIS LINK ADJUSTMENT METHOD AND RELATED DEVICE

#9 | 2019-01-10

US20190010135A1

Chemistry; metallurgy

1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

#10 | 2017-07-06

US20170190681A1

Chemistry; metallurgy

1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

#11 | 2015-05-21

US20150139016A1

Electricity

Adaptive frequency domain resource configuration method, apparatus, and communications system

InventorID:

1166705 ⎘